Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALZ-Pilot in early Alzheimer's disease
2016-002317-22Phase 2Completed
- Sponsor
- Geriatric Centre, Umeå University Hospital
- Start
- Sep 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valaciclovir in Alzheimer's disease (AD), sponsored by Geriatric Centre, Umeå University Hospital. Primary endpoints: Change in total tau and neurofilament light chain and Feasibility of [18F]-FHBG PET/CT for detecting replicating HSV. Started Sep 2016; status: completed.
02
Drugs
valaciclovir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2016-002317-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002317-22.